{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:31:54Z","timestamp":1786440714904,"version":"build-2736575974"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02416-w","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:45:33Z","timestamp":1786437933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pain in Parkinson\u2019s disease: bridging pathophysiology, clinical features, and personalized management"],"prefix":"10.1186","volume":"27","author":[{"given":"Thalis","family":"Asimakopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Psychari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rekatsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinovia","family":"Kefalopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2416_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"key":"2416_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/brain\/awab001","volume":"144","author":"A Mostofi","year":"2021","unstructured":"Mostofi A, Morgante F, Edwards MJ et al (2021) Pain in Parkinson\u2019s disease and the role of the subthalamic nucleus. Brain 144:1342\u20131350. https:\/\/doi.org\/10.1093\/brain\/awab001","journal-title":"Brain"},{"key":"2416_CR3","doi-asserted-by":"publisher","unstructured":"Buhmann C, Kassubek J, Jost WH Management of pain in Parkinson\u2019s disease. J Parkinsons Dis 10:S37\u2013S48. https:\/\/doi.org\/10.3233\/JPD-202069","DOI":"10.3233\/JPD-202069"},{"key":"2416_CR4","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/j.pain.0000000000002107","volume":"162","author":"V Mylius","year":"2021","unstructured":"Mylius V, Perez Lloret S, Cury RG et al (2021) The Parkinson disease pain classification system: results from an international mechanism-based classification approach. Pain 162:1201\u20131210. https:\/\/doi.org\/10.1097\/j.pain.0000000000002107","journal-title":"Pain"},{"key":"2416_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.parkreldis.2018.06.001","volume":"56","author":"MA Silverdale","year":"2018","unstructured":"Silverdale MA, Kobylecki C, Kass-Iliyya L et al (2018) A detailed clinical study of pain in 1957 participants with early\/moderate Parkinson\u2019s disease. Parkinsonism Relat Disord 56:27\u201332. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.001","journal-title":"Parkinsonism Relat Disord"},{"key":"2416_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prdoa.2019.11.004","volume":"2","author":"Y-C Tai","year":"2020","unstructured":"Tai Y-C, Lin C-H (2020) An overview of pain in Parkinson\u2019s disease. Clin Parkinsonism Relat Disorders 2:1\u20138. https:\/\/doi.org\/10.1016\/j.prdoa.2019.11.004","journal-title":"Clin Parkinsonism Relat Disorders"},{"key":"2416_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S (2019) SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 4:5. https:\/\/doi.org\/10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"2416_CR8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0967-5868(98)90204-1","volume":"5","author":"B Ford","year":"1998","unstructured":"Ford B (1998) Pain in Parkinson\u2019s disease. Clin Neurosci 5:63\u201372","journal-title":"Clin Neurosci"},{"key":"2416_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.870010106","volume":"1","author":"CG Goetz","year":"1986","unstructured":"Goetz CG, Tanner CM, Levy M et al (1986) Pain in Parkinson\u2019s disease. Mov Disord 1:45\u201349. https:\/\/doi.org\/10.1002\/mds.870010106","journal-title":"Mov Disord"},{"key":"2416_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1474-4422(25)00033-X","volume":"24","author":"M Tinazzi","year":"2025","unstructured":"Tinazzi M, Gandolfi M, Artusi CA et al (2025) Advances in diagnosis, classification, and management of pain in Parkinson\u2019s disease. Lancet Neurol 24:331\u2013347. https:\/\/doi.org\/10.1016\/S1474-4422(25)00033-X","journal-title":"Lancet Neurol"},{"key":"2416_CR11","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/j.pain.0000000000000904","volume":"158","author":"W-H Lien","year":"2017","unstructured":"Lien W-H, Lien W-C, Kuan T-S et al (2017) Parkinson disease and musculoskeletal pain: an 8-year population-based cohort study. Pain 158:1234\u20131240. https:\/\/doi.org\/10.1097\/j.pain.0000000000000904","journal-title":"Pain"},{"key":"2416_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000003138","author":"V Mylius","year":"2024","unstructured":"Mylius V, Moisset X, Rukavina K et al (2024) New ICD-11 diagnostic criteria for chronic secondary musculoskeletal pain associated with Parkinson disease. Pain. https:\/\/doi.org\/10.1097\/j.pain.0000000000003138","journal-title":"Pain"},{"key":"2416_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/mds.30046","volume":"40","author":"F Vazirian","year":"2025","unstructured":"Vazirian F, Tian J, Jane, Alty et al (2025) Chronic Musculoskeletal Pain and Risk of Incident Parkinson\u2019s Disease: A 13-Year Longitudinal Study. Mov Disord 40:87\u201396. https:\/\/doi.org\/10.1002\/mds.30046","journal-title":"Mov Disord"},{"key":"2416_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2017.10.010","volume":"87","author":"PJ Blanchet","year":"2018","unstructured":"Blanchet PJ, Brefel-Courbon C (2018) Chronic pain and pain processing in Parkinson\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 87:200\u2013206. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.10.010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2416_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2217\/nmt-2021-0011","volume":"11","author":"LE Tueth","year":"2021","unstructured":"Tueth LE, Duncan RP (2021) Musculoskeletal Pain in Parkinson\u2019s Disease: A Narrative Review. Neurodegener Dis Manag 11:373\u2013385. https:\/\/doi.org\/10.2217\/nmt-2021-0011","journal-title":"Neurodegener Dis Manag"},{"key":"2416_CR16","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.26270","volume":"30","author":"KR Chaudhuri","year":"2015","unstructured":"Chaudhuri KR, Rizos A, Trenkwalder C et al (2015) King\u2019s Parkinson\u2019s disease pain scale, the first scale for pain in PD: An international validation: King\u2019s PD Pain Scale Validation. Mov Disord 30:1623\u20131631. https:\/\/doi.org\/10.1002\/mds.26270","journal-title":"Mov Disord"},{"key":"2416_CR17","doi-asserted-by":"publisher","unstructured":"Ford B (2010) Pain in Parkinson\u2019s disease. Mov Disord 25. https:\/\/doi.org\/10.1002\/mds.22716","DOI":"10.1002\/mds.22716"},{"key":"2416_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mdc3.12217","volume":"2","author":"V Mylius","year":"2015","unstructured":"Mylius V, Ciampi De Andrade D, Cury RG et al (2015) Pain in Parkinson\u2019s Disease: Current Concepts and a New Diagnostic Algorithm. Mov Disord Clin Pract 2:357\u2013364. https:\/\/doi.org\/10.1002\/mdc3.12217","journal-title":"Mov Disord Clin Pract"},{"key":"2416_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G (2010) Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9:807\u2013819. https:\/\/doi.org\/10.1016\/S1474-4422(10)70143-5","journal-title":"Lancet Neurol"},{"key":"2416_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2018.06.022","volume":"392","author":"JK Adewusi","year":"2018","unstructured":"Adewusi JK, Hadjivassiliou M, Vinagre-Arag\u00f3n A et al (2018) Peripheral neuropathic pain in idiopathic Parkinson\u2019s disease: Prevalence and impact on quality of life; a case controlled study. J Neurol Sci 392:3\u20137. https:\/\/doi.org\/10.1016\/j.jns.2018.06.022","journal-title":"J Neurol Sci"},{"key":"2416_CR21","doi-asserted-by":"publisher","first-page":"102374","DOI":"10.1016\/j.arr.2024.102374","volume":"99","author":"LG Pereira","year":"2024","unstructured":"Pereira LG, Rodrigues P, Viero FT et al (2024) Prevalence of radicular neuropathic pain in idiopathic Parkinson\u2019s disease: A systematic review and meta-analysis. Ageing Res Rev 99:102374. https:\/\/doi.org\/10.1016\/j.arr.2024.102374","journal-title":"Ageing Res Rev"},{"key":"2416_CR22","doi-asserted-by":"publisher","first-page":"fcae210","DOI":"10.1093\/braincomms\/fcae210","volume":"6","author":"D Nardelli","year":"2024","unstructured":"Nardelli D, Gambioli F, De Bartolo MI et al (2024) Pain in Parkinson\u2019s disease: a neuroanatomy-based approach. Brain Commun 6:fcae210. https:\/\/doi.org\/10.1093\/braincomms\/fcae210","journal-title":"Brain Commun"},{"key":"2416_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","volume":"8","author":"G Wasner","year":"2012","unstructured":"Wasner G, Deuschl G (2012) Pains in Parkinson disease\u2014many syndromes under one umbrella. Nat Rev Neurol 8:284\u2013294. https:\/\/doi.org\/10.1038\/nrneurol.2012.54","journal-title":"Nat Rev Neurol"},{"key":"2416_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","volume":"136","author":"D Bouhassira","year":"2008","unstructured":"Bouhassira D, Lant\u00e9ri-Minet M, Attal N et al (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380\u2013387. https:\/\/doi.org\/10.1016\/j.pain.2007.08.013","journal-title":"Pain"},{"key":"2416_CR25","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","volume":"157","author":"E Kosek","year":"2016","unstructured":"Kosek E, Cohen M, Baron R et al (2016) Do we need a third mechanistic descriptor for chronic pain states? Pain 157:1382\u20131386. https:\/\/doi.org\/10.1097\/j.pain.0000000000000507","journal-title":"Pain"},{"key":"2416_CR26","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1097\/j.pain.0000000000002324","volume":"162","author":"E Kosek","year":"2021","unstructured":"Kosek E, Clauw D, Nijs J et al (2021) Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain 162:2629\u20132634. https:\/\/doi.org\/10.1097\/j.pain.0000000000002324","journal-title":"Pain"},{"key":"2416_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.31083\/j.jin2205132","volume":"22","author":"C Cattaneo","year":"2023","unstructured":"Cattaneo C, Jost WH (2023) Pain in Parkinson\u2019s Disease: Pathophysiology, Classification and Treatment. J Integr Neurosci 22:132. https:\/\/doi.org\/10.31083\/j.jin2205132","journal-title":"J Integr Neurosci"},{"key":"2416_CR28","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/archneur.59.3.421","volume":"59","author":"WG Ondo","year":"2002","unstructured":"Ondo WG, Vuong KD, Jankovic J (2002) Exploring the Relationship Between Parkinson Disease and Restless Legs Syndrome. Arch Neurol 59:421. https:\/\/doi.org\/10.1001\/archneur.59.3.421","journal-title":"Arch Neurol"},{"key":"2416_CR29","doi-asserted-by":"publisher","first-page":"174480692199902","DOI":"10.1177\/1744806921999025","volume":"17","author":"J-S Lu","year":"2021","unstructured":"Lu J-S, Chen Q-Y, Chen X et al (2021) Cellular and synaptic mechanisms for Parkinson\u2019s disease-related chronic pain. Mol Pain 17:1744806921999025. https:\/\/doi.org\/10.1177\/1744806921999025","journal-title":"Mol Pain"},{"key":"2416_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1082-3174(96)80026-2","volume":"5","author":"M-M Backonja","year":"1996","unstructured":"Backonja M-M (1996) Primary somatosensory cortex and pain perception. Pain Forum 5:174\u2013180. https:\/\/doi.org\/10.1016\/S1082-3174(96)80026-2","journal-title":"Pain Forum"},{"key":"2416_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neubiorev.2018.03.022","volume":"90","author":"X Xiao","year":"2018","unstructured":"Xiao X, Zhang Y-Q (2018) A new perspective on the anterior cingulate cortex and affective pain. Neurosci Biobehavioral Reviews 90:200\u2013211. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.03.022","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"2416_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.28461","volume":"36","author":"L Chen","year":"2021","unstructured":"Chen L, Bedard P, Hallett M, Horovitz SG (2021) Dynamics of Top-Down Control and Motor Networks in Parkinson\u2019s Disease. Mov Disord 36:916\u2013926. https:\/\/doi.org\/10.1002\/mds.28461","journal-title":"Mov Disord"},{"key":"2416_CR33","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/brainsci14080741","volume":"14","author":"G Galdino","year":"2024","unstructured":"Galdino G, Veras FP, Dos Anjos-Garcia T (2024) The Role of the Thalamus in Nociception: Important but Forgotten. Brain Sci 14:741. https:\/\/doi.org\/10.3390\/brainsci14080741","journal-title":"Brain Sci"},{"key":"2416_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neuroscience.2012.12.021","volume":"232","author":"H-J You","year":"2013","unstructured":"You H-J, Lei J, Niu N et al (2013) Specific thalamic nuclei function as novel \u2018nociceptive discriminators\u2019 in the endogenous control of nociception in rats. Neuroscience 232:53\u201363. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.12.021","journal-title":"Neuroscience"},{"key":"2416_CR35","doi-asserted-by":"publisher","first-page":"R580","DOI":"10.1016\/j.cub.2017.05.010","volume":"27","author":"N Gogolla","year":"2017","unstructured":"Gogolla N (2017) The insular cortex. Curr Biol 27:R580\u2013R586. https:\/\/doi.org\/10.1016\/j.cub.2017.05.010","journal-title":"Curr Biol"},{"key":"2416_CR36","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.neuron.2020.06.017","volume":"107","author":"J Deng","year":"2020","unstructured":"Deng J, Zhou H, Lin J-K et al (2020) The Parabrachial Nucleus Directly Channels Spinal Nociceptive Signals to the Intralaminar Thalamic Nuclei, but Not the Amygdala. Neuron 107:909\u2013923e6. https:\/\/doi.org\/10.1016\/j.neuron.2020.06.017","journal-title":"Neuron"},{"key":"2416_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-023-00469-1","volume":"9","author":"J Wang","year":"2023","unstructured":"Wang J, Sun L, Chen L et al (2023) Common and distinct roles of amygdala subregional functional connectivity in non-motor symptoms of Parkinson\u2019s disease. npj Parkinsons Dis 9:28. https:\/\/doi.org\/10.1038\/s41531-023-00469-1","journal-title":"npj Parkinsons Dis"},{"key":"2416_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.brainresrev.2008.12.009","volume":"60","author":"MM Heinricher","year":"2009","unstructured":"Heinricher MM, Tavares I, Leith JL, Lumb BM (2009) Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev 60:214\u2013225. https:\/\/doi.org\/10.1016\/j.brainresrev.2008.12.009","journal-title":"Brain Res Rev"},{"key":"2416_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ana.410040511","volume":"4","author":"AI Basbaum","year":"1978","unstructured":"Basbaum AI, Fields HL (1978) Endogenous pain control mechanisms: Review and hypothesis. Ann Neurol 4:451\u2013462. https:\/\/doi.org\/10.1002\/ana.410040511","journal-title":"Ann Neurol"},{"key":"2416_CR40","doi-asserted-by":"publisher","unstructured":"Grinberg LT, Rueb U, Heinsen H (2011) Brainstem: neglected locus in neurodegenerative diseases. Front Neur 2. https:\/\/doi.org\/10.3389\/fneur.2011.00042","DOI":"10.3389\/fneur.2011.00042"},{"key":"2416_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0304-3959(94)00172-B","volume":"60","author":"EH Chudler","year":"1995","unstructured":"Chudler EH, Dong WK (1995) The role of the basal ganglia in nociception and pain. Pain 60:3\u201338. https:\/\/doi.org\/10.1016\/0304-3959(94)00172-B","journal-title":"Pain"},{"key":"2416_CR42","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1186\/1744-8069-6-27","volume":"6","author":"D Borsook","year":"2010","unstructured":"Borsook D, Upadhyay J, Chudler EH, Becerra L (2010) A Key Role of the Basal Ganglia in Pain and Analgesia - Insights Gained through Human Functional Imaging. Mol Pain 6:1744. https:\/\/doi.org\/10.1186\/1744-8069-6-27. -8069-6\u201327","journal-title":"Mol Pain"},{"key":"2416_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41531-023-00516-x","volume":"9","author":"A Pautrat","year":"2023","unstructured":"Pautrat A, Al Tannir R, Pernet-Gallay K et al (2023) Altered parabrachial nucleus nociceptive processing may underlie central pain in Parkinson\u2019s disease. npj Parkinsons Dis 9:78. https:\/\/doi.org\/10.1038\/s41531-023-00516-x","journal-title":"npj Parkinsons Dis"},{"key":"2416_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s44158-024-00169-z","volume":"4","author":"M Mancini","year":"2024","unstructured":"Mancini M, Calculli A, Di Martino D, Pisani A (2024) Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson\u2019s disease. J Anesth Analg Crit Care 4:33. https:\/\/doi.org\/10.1186\/s44158-024-00169-z","journal-title":"J Anesth Analg Crit Care"},{"key":"2416_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0006-8993(03)03318-3","volume":"987","author":"BK Taylor","year":"2003","unstructured":"Taylor BK, Joshi C, Uppal H (2003) Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 987:135\u2013143. https:\/\/doi.org\/10.1016\/S0006-8993(03)03318-3","journal-title":"Brain Res"},{"key":"2416_CR46","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1111\/j.1460-9568.2004.03622.x","volume":"20","author":"A Pertovaara","year":"2004","unstructured":"Pertovaara A, Martikainen IK, Hagelberg N et al (2004) Striatal dopamine D2\/D3 receptor availability correlates with individual response characteristics to pain. Eur J Neurosci 20:1587\u20131592. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03622.x","journal-title":"Eur J Neurosci"},{"key":"2416_CR47","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ (2009) Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity. J Pain 10:895\u2013926. https:\/\/doi.org\/10.1016\/j.jpain.2009.06.012","journal-title":"J Pain"},{"key":"2416_CR48","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/ejn.16106","volume":"59","author":"Y Baranoglu Kilinc","year":"2024","unstructured":"Baranoglu Kilinc Y, Torun IE, Kilinc E (2024) D2 dopamine receptor-mediated mechanisms of dopaminergic system modulation in in vivo and in vitro experimental models of migraine. Eur J Neurosci 59:1177\u20131193. https:\/\/doi.org\/10.1111\/ejn.16106","journal-title":"Eur J Neurosci"},{"key":"2416_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrn2947","volume":"11","author":"AJ Todd","year":"2010","unstructured":"Todd AJ (2010) Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 11:823\u2013836. https:\/\/doi.org\/10.1038\/nrn2947","journal-title":"Nat Rev Neurosci"},{"key":"2416_CR50","doi-asserted-by":"publisher","unstructured":"Rodriguez MC, Obeso JA, Olanow CW (1998) Subthalamic nucleus-mediated excitotoxicity in parkinson\u2019s disease: a target for neuroprotection. Ann Neurol 44. https:\/\/doi.org\/10.1002\/ana.410440726","DOI":"10.1002\/ana.410440726"},{"key":"2416_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejphar.2008.02.027","volume":"584","author":"S Sarre","year":"2008","unstructured":"Sarre S, Lanza M, Makovec F et al (2008) In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats. Eur J Pharmacol 584:297\u2013305. https:\/\/doi.org\/10.1016\/j.ejphar.2008.02.027","journal-title":"Eur J Pharmacol"},{"key":"2416_CR52","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2174\/187152709789824606","volume":"8","author":"K Johnson","year":"2009","unstructured":"Johnson K, Conn P, Niswender C (2009) Glutamate Receptors as Therapeutic Targets for Parkinsons Disease. CNSNDDT 8:475\u2013491. https:\/\/doi.org\/10.2174\/187152709789824606","journal-title":"CNSNDDT"},{"key":"2416_CR53","doi-asserted-by":"publisher","unstructured":"Petrenko AB, Yamakura T, Baba H, Shimoji K (2003) The role of N-Methyl-d-Aspartate (NMDA) receptors in pain: a review. Anesth Analgesia 1108\u20131116. https:\/\/doi.org\/10.1213\/01.ANE.0000081061.12235.55","DOI":"10.1213\/01.ANE.0000081061.12235.55"},{"key":"2416_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fnmol.2018.00383","volume":"11","author":"M Mazzitelli","year":"2018","unstructured":"Mazzitelli M, Palazzo E, Maione S, Neugebauer V (2018) Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation. Front Mol Neurosci 11:383. https:\/\/doi.org\/10.3389\/fnmol.2018.00383","journal-title":"Front Mol Neurosci"},{"key":"2416_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","volume":"36","author":"L Brichta","year":"2013","unstructured":"Brichta L, Greengard P, Flajolet M (2013) Advances in the pharmacological treatment of Parkinson\u2019s disease: targeting neurotransmitter systems. Trends Neurosci 36:543\u2013554. https:\/\/doi.org\/10.1016\/j.tins.2013.06.003","journal-title":"Trends Neurosci"},{"key":"2416_CR56","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","volume":"277","author":"M Politis","year":"2015","unstructured":"Politis M, Niccolini F (2015) Serotonin in Parkinson\u2019s disease. Behav Brain Res 277:136\u2013145. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.037","journal-title":"Behav Brain Res"},{"key":"2416_CR57","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41386-023-01620-5","volume":"48","author":"Y Alvarez-Bagnarol","year":"2023","unstructured":"Alvarez-Bagnarol Y, Garc\u00eda R, Vendruscolo LF, Morales M (2023) Inhibition of dorsal raphe GABAergic neurons blocks hyperalgesia during heroin withdrawal. Neuropsychopharmacol 48:1300\u20131308. https:\/\/doi.org\/10.1038\/s41386-023-01620-5","journal-title":"Neuropsychopharmacol"},{"key":"2416_CR58","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1080\/14656566.2019.1639672","volume":"20","author":"WH Jost","year":"2019","unstructured":"Jost WH, Buhmann C (2019) The challenge of pain in the pharmacological management of Parkinson\u2019s disease. Expert Opin Pharmacother 20:1847\u20131854. https:\/\/doi.org\/10.1080\/14656566.2019.1639672","journal-title":"Expert Opin Pharmacother"},{"key":"2416_CR59","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","volume":"66","author":"MJ Millan","year":"2002","unstructured":"Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355\u2013474. https:\/\/doi.org\/10.1016\/S0301-0082(02)00009-6","journal-title":"Prog Neurobiol"},{"key":"2416_CR60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuropharm.2016.12.024","volume":"116","author":"E Kilinc","year":"2017","unstructured":"Kilinc E, Guerrero-Toro C, Zakharov A et al (2017) Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain. Neuropharmacology 116:160\u2013173. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.12.024","journal-title":"Neuropharmacology"},{"key":"2416_CR61","doi-asserted-by":"publisher","first-page":"e14446","DOI":"10.1111\/cns.14446","volume":"30","author":"Q Gao","year":"2024","unstructured":"Gao Q, Zhang Y, Wang X et al (2024) Regulation of nociception threshold by norepinephrine through adrenergic \u03b12 receptor in rat models of Parkinson\u2019s disease. CNS Neurosci Ther 30:e14446. https:\/\/doi.org\/10.1111\/cns.14446","journal-title":"CNS Neurosci Ther"},{"key":"2416_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6383240","volume":"2016","author":"L-F Cao","year":"2016","unstructured":"Cao L-F, Peng X-Y, Huang Y et al (2016) Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson\u2019s Disease. Neural Plast 2016:1\u201316. https:\/\/doi.org\/10.1155\/2016\/6383240","journal-title":"Neural Plast"},{"key":"2416_CR63","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR (2011) Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior. Anesthesiology 115:1363\u20131381. https:\/\/doi.org\/10.1097\/ALN.0b013e318238bba6","journal-title":"Anesthesiology"},{"key":"2416_CR64","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fneur.2018.00524","volume":"9","author":"S Sgroi","year":"2018","unstructured":"Sgroi S, Tonini R (2018) Opioidergic Modulation of Striatal Circuits, Implications in Parkinson\u2019s Disease and Levodopa Induced Dyskinesia. Front Neurol 9:524. https:\/\/doi.org\/10.3389\/fneur.2018.00524","journal-title":"Front Neurol"},{"key":"2416_CR65","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ana.410420508","volume":"42","author":"P Piccini","year":"1997","unstructured":"Piccini P, Weeks RA, Brooks DJ (1997) Alterations in opioid receptor binding in Parkinson\u2019s disease patients with levodopa-induced dyskinesias. Ann Neurol 42:720\u2013726. https:\/\/doi.org\/10.1002\/ana.410420508","journal-title":"Ann Neurol"},{"key":"2416_CR66","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S1474-4422(15)00243-4","volume":"14","author":"C Trenkwalder","year":"2015","unstructured":"Trenkwalder C, Chaudhuri KR, Martinez-Martin P et al (2015) Prolonged-release oxycodone\u2013naloxone for treatment of severe pain in patients with Parkinson\u2019s disease (PANDA): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 14:1161\u20131170. https:\/\/doi.org\/10.1016\/S1474-4422(15)00243-4","journal-title":"Lancet Neurol"},{"key":"2416_CR67","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00415-012-6754-5","volume":"260","author":"A Truini","year":"2013","unstructured":"Truini A, Frontoni M, Cruccu G (2013) Parkinson\u2019s disease related pain: a review of recent findings. J Neurol 260:330\u2013334. https:\/\/doi.org\/10.1007\/s00415-012-6754-5","journal-title":"J Neurol"},{"key":"2416_CR68","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/JPR.S446803","volume":"17","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zheng H, Yu Q, Jing X (2024) Understanding of Spinal Wide Dynamic Range Neurons and Their Modulation on Pathological Pain. JPR Volume 17:441\u2013457. https:\/\/doi.org\/10.2147\/JPR.S446803","journal-title":"JPR Volume"},{"key":"2416_CR69","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JPD-181513","volume":"9","author":"O Fr\u00fcndt","year":"2019","unstructured":"Fr\u00fcndt O, Grashorn W, Buhmann C et al (2019) Quantitative Sensory Testing (QST) in Drug-Na\u00efve Patients with Parkinson\u2019s Disease. JPD 9:369\u2013378. https:\/\/doi.org\/10.3233\/JPD-181513","journal-title":"JPD"},{"key":"2416_CR70","doi-asserted-by":"publisher","first-page":"e12137","DOI":"10.1111\/jabr.12137","volume":"23","author":"SE Harte","year":"2018","unstructured":"Harte SE, Harris RE, Clauw DJ (2018) The neurobiology of central sensitization. J Appl Biobehavioral Res 23:e12137. https:\/\/doi.org\/10.1111\/jabr.12137","journal-title":"J Appl Biobehavioral Res"},{"key":"2416_CR71","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1523\/JNEUROSCI.2411-06.2007","volume":"27","author":"J Sarnthein","year":"2007","unstructured":"Sarnthein J, Jeanmonod D (2007) High Thalamocortical Theta Coherence in Patients with Parkinson\u2019s Disease. J Neurosci 27:124\u2013131. https:\/\/doi.org\/10.1523\/JNEUROSCI.2411-06.2007","journal-title":"J Neurosci"},{"key":"2416_CR72","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41467-018-02820-0","volume":"9","author":"S Vanneste","year":"2018","unstructured":"Vanneste S, Song J-J, De Ridder D (2018) Thalamocortical dysrhythmia detected by machine learning. Nat Commun 9:1103. https:\/\/doi.org\/10.1038\/s41467-018-02820-0","journal-title":"Nat Commun"},{"key":"2416_CR73","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3390\/ijms20133130","volume":"20","author":"S Yang","year":"2019","unstructured":"Yang S, Chang MC (2019) Chronic Pain: Structural and Functional Changes in Brain Structures and Associated Negative Affective States. IJMS 20:3130. https:\/\/doi.org\/10.3390\/ijms20133130","journal-title":"IJMS"},{"key":"2416_CR74","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/SPC.0000000000000055","volume":"8","author":"MH Ossipov","year":"2014","unstructured":"Ossipov MH, Morimura K, Porreca F (2014) Descending pain modulation and chronification of pain. Curr Opin Supportive Palliat Care 8:143\u2013151. https:\/\/doi.org\/10.1097\/SPC.0000000000000055","journal-title":"Curr Opin Supportive Palliat Care"},{"key":"2416_CR75","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fphar.2020.00435","volume":"11","author":"E Paredes-Rodriguez","year":"2020","unstructured":"Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T et al (2020) The Noradrenergic System in Parkinson\u2019s Disease. Front Pharmacol 11:435. https:\/\/doi.org\/10.3389\/fphar.2020.00435","journal-title":"Front Pharmacol"},{"key":"2416_CR76","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/brainsci11091224","volume":"11","author":"K Kinugawa","year":"2021","unstructured":"Kinugawa K, Mano T, Sugie K (2021) Neuronal Dynamics of Pain in Parkinson\u2019s Disease. Brain Sci 11:1224. https:\/\/doi.org\/10.3390\/brainsci11091224","journal-title":"Brain Sci"},{"key":"2416_CR77","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1523\/JNEUROSCI.4123-07.2008","volume":"28","author":"MN Baliki","year":"2008","unstructured":"Baliki MN, Geha PY, Apkarian AV, Chialvo DR (2008) Beyond Feeling: Chronic Pain Hurts the Brain, Disrupting the Default-Mode Network Dynamics. J Neurosci 28:1398\u20131403. https:\/\/doi.org\/10.1523\/JNEUROSCI.4123-07.2008","journal-title":"J Neurosci"},{"key":"2416_CR78","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pneurobio.2013.02.003","volume":"104","author":"D Borsook","year":"2013","unstructured":"Borsook D, Edwards R, Elman I et al (2013) Pain and analgesia: The value of salience circuits. Prog Neurobiol 104:93\u2013105. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.02.003","journal-title":"Prog Neurobiol"},{"key":"2416_CR79","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/ejp.2153","volume":"27","author":"N Neumann","year":"2023","unstructured":"Neumann N, Domin M, Schmidt C, Lotze M (2023) Chronic pain is associated with less grey matter volume in the anterior cingulum, anterior and posterior insula and hippocampus across three different chronic pain conditions. Eur J Pain 27:1239\u20131248. https:\/\/doi.org\/10.1002\/ejp.2153","journal-title":"Eur J Pain"},{"key":"2416_CR80","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.parkreldis.2015.10.019","volume":"21","author":"L Kass-Iliyya","year":"2015","unstructured":"Kass-Iliyya L, Javed S, Gosal D et al (2015) Small fiber neuropathy in Parkinson\u2019s disease: A clinical, pathological and corneal confocal microscopy study. Parkinsonism Relat Disord 21:1454\u20131460. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.10.019","journal-title":"Parkinsonism Relat Disord"},{"key":"2416_CR81","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3233\/JPD-191697","volume":"9","author":"M Jeziorska","year":"2019","unstructured":"Jeziorska M, Atkinson A, Kass-Iliyya L et al (2019) Small Fibre Neuropathy in Parkinson\u2019s Disease: Comparison of Skin Biopsies from the More Affected and Less Affected Sides. JPD 9:761\u2013765. https:\/\/doi.org\/10.3233\/JPD-191697","journal-title":"JPD"},{"key":"2416_CR82","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0b013e3182a9f449","volume":"81","author":"N Wang","year":"2013","unstructured":"Wang N, Gibbons CH, Lafo J, Freeman R (2013) \u03b1-Synuclein in cutaneous autonomic nerves. Neurology 81:1604\u20131610. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a9f449","journal-title":"Neurology"},{"key":"2416_CR83","doi-asserted-by":"publisher","first-page":"885500","DOI":"10.3389\/fnagi.2022.885500","volume":"14","author":"X-Y Gao","year":"2022","unstructured":"Gao X-Y, Yang T, Gu Y, Sun X-H (2022) Mitochondrial Dysfunction in Parkinson\u2019s Disease: From Mechanistic Insights to Therapy. Front Aging Neurosci 14:885500. https:\/\/doi.org\/10.3389\/fnagi.2022.885500","journal-title":"Front Aging Neurosci"},{"key":"2416_CR84","doi-asserted-by":"publisher","first-page":"105940","DOI":"10.1016\/j.nbd.2022.105940","volume":"176","author":"A Gopinath","year":"2023","unstructured":"Gopinath A, Mackie PM, Phan LT et al (2023) The complex role of inflammation and gliotransmitters in Parkinson\u2019s disease. Neurobiol Dis 176:105940. https:\/\/doi.org\/10.1016\/j.nbd.2022.105940","journal-title":"Neurobiol Dis"},{"key":"2416_CR85","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12325-019-01148-5","volume":"37","author":"M Rekatsina","year":"2020","unstructured":"Rekatsina M, Paladini A, Piroli A et al (2020) Pathophysiology and Therapeutic Perspectives of Oxidative Stress and Neurodegenerative Diseases: A Narrative Review. Adv Ther 37:113\u2013139. https:\/\/doi.org\/10.1007\/s12325-019-01148-5","journal-title":"Adv Ther"},{"key":"2416_CR86","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fncel.2019.00116","volume":"13","author":"Z Wei","year":"2019","unstructured":"Wei Z, Fei Y, Su W, Chen G (2019) Emerging Role of Schwann Cells in Neuropathic Pain: Receptors, Glial Mediators and Myelination. Front Cell Neurosci 13:116. https:\/\/doi.org\/10.3389\/fncel.2019.00116","journal-title":"Front Cell Neurosci"},{"key":"2416_CR87","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.neuron.2019.01.047","volume":"101","author":"LA McDermott","year":"2019","unstructured":"McDermott LA, Weir GA, Themistocleous AC et al (2019) Defining the Functional Role of NaV1.7 in Human Nociception. Neuron 101:905\u2013919e8. https:\/\/doi.org\/10.1016\/j.neuron.2019.01.047","journal-title":"Neuron"},{"key":"2416_CR88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.arr.2017.01.005","volume":"35","author":"T Thompson","year":"2017","unstructured":"Thompson T, Gallop K, Correll CU et al (2017) Pain perception in Parkinson\u2019s disease: A systematic review and meta-analysis of experimental studies. Ageing Res Rev 35:74\u201386. https:\/\/doi.org\/10.1016\/j.arr.2017.01.005","journal-title":"Ageing Res Rev"},{"key":"2416_CR89","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00415-010-5812-0","volume":"258","author":"S Zambito Marsala","year":"2011","unstructured":"Zambito Marsala S, Tinazzi M, Vitaliani R et al (2011) Spontaneous pain, pain threshold, and pain tolerance in Parkinson\u2019s disease. J Neurol 258:627\u2013633. https:\/\/doi.org\/10.1007\/s00415-010-5812-0","journal-title":"J Neurol"},{"key":"2416_CR90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2016.10.019","volume":"34","author":"S Zambito-Marsala","year":"2017","unstructured":"Zambito-Marsala S, Erro R, Bacchin R et al (2017) Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials. Parkinsonism Relat Disord 34:43\u201348. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.019","journal-title":"Parkinsonism Relat Disord"},{"key":"2416_CR91","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/ene.12188","volume":"20","author":"Y Granovsky","year":"2013","unstructured":"Granovsky Y, Schlesinger I, Fadel S et al (2013) Asymmetric pain processing in Parkinson\u2019s disease. Eur J Neurol 20:1375\u20131382. https:\/\/doi.org\/10.1111\/ene.12188","journal-title":"Eur J Neurol"},{"key":"2416_CR92","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jocn.2012.05.043","volume":"20","author":"T Tykocki","year":"2013","unstructured":"Tykocki T, Kornakiewicz A, Mandat T, Nauman P (2013) Pain perception in patients with Parkinson\u2019s disease. J Clin Neurosci 20:663\u2013666. https:\/\/doi.org\/10.1016\/j.jocn.2012.05.043","journal-title":"J Clin Neurosci"},{"key":"2416_CR93","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.parkreldis.2006.04.003","volume":"13","author":"L Vela","year":"2007","unstructured":"Vela L, Lyons KE, Singer C, Lieberman AN (2007) Pain-pressure threshold in patients with Parkinson\u2019s disease with and without dyskinesia. Parkinsonism Relat Disord 13:189\u2013192. https:\/\/doi.org\/10.1016\/j.parkreldis.2006.04.003","journal-title":"Parkinsonism Relat Disord"},{"key":"2416_CR94","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fneur.2016.00104","volume":"7","author":"X Zhuang","year":"2016","unstructured":"Zhuang X, Chen Y, Zhuang X et al (2016) Contribution of Pro-inflammatory Cytokine Signaling within Midbrain Periaqueductal Gray to Pain Sensitivity in Parkinson\u2019s Disease via GABAergic Pathway. Front Neurol 7:104. https:\/\/doi.org\/10.3389\/fneur.2016.00104","journal-title":"Front Neurol"},{"key":"2416_CR95","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/ene.13691","volume":"25","author":"P Martinez-Martin","year":"2018","unstructured":"Martinez-Martin P, Rizos AM, Wetmore J et al (2018) First comprehensive tool for screening pain in Parkinson\u2019s disease: the King\u2019s Parkinson\u2019s Disease Pain Questionnaire. Eur J Neurol 25:1255\u20131261. https:\/\/doi.org\/10.1111\/ene.13691","journal-title":"Eur J Neurol"},{"key":"2416_CR96","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM et al (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov Disord 26:399\u2013406. https:\/\/doi.org\/10.1002\/mds.23462","journal-title":"Mov Disord"},{"key":"2416_CR97","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri KR, Martinez-Martin P, Brown RG et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: Results from an international pilot study. Mov Disord 22:1901\u20131911. https:\/\/doi.org\/10.1002\/mds.21596","journal-title":"Mov Disord"},{"key":"2416_CR98","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mdc3.12384","volume":"3","author":"S Perez-Lloret","year":"2016","unstructured":"Perez-Lloret S, Ciampi de Andrade D, Lyons KE et al (2016) Rating Scales for Pain in Parkinson\u2019s Disease: Critique and Recommendations. Mov Disord Clin Pract 3:527\u2013537. https:\/\/doi.org\/10.1002\/mdc3.12384","journal-title":"Mov Disord Clin Pract"},{"key":"2416_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07985-9","author":"M Tinazzi","year":"2025","unstructured":"Tinazzi M, Geroin C, Siciliano M et al (2025) Pain and fatigue in Parkinson\u2019s disease: advances in diagnosis and management. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-024-07985-9","journal-title":"Neurol Sci"},{"key":"2416_CR100","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1212\/WNL.0000000000000887","volume":"83","author":"RG Cury","year":"2014","unstructured":"Cury RG, Galhardoni R, Fonoff ET et al (2014) Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease. Neurology 83:1403\u20131409. https:\/\/doi.org\/10.1212\/WNL.0000000000000887","journal-title":"Neurology"},{"key":"2416_CR101","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.22142","volume":"23","author":"L N\u00e8gre-Pag\u00e8s","year":"2008","unstructured":"N\u00e8gre-Pag\u00e8s L, Regragui W, Bouhassira D et al (2008) Chronic pain in Parkinson\u2019s disease: the cross-sectional French DoPaMiP survey. Mov Disord 23:1361\u20131369. https:\/\/doi.org\/10.1002\/mds.22142","journal-title":"Mov Disord"},{"key":"2416_CR102","first-page":"194","volume":"21","author":"JL Riley","year":"2007","unstructured":"Riley JL, Myers CD, Currie TP et al (2007) Self-care behaviors associated with myofascial temporomandibular disorder pain. J Orofac Pain 21:194\u2013202","journal-title":"J Orofac Pain"},{"key":"2416_CR103","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/medicina58111684","volume":"58","author":"E Angelopoulou","year":"2022","unstructured":"Angelopoulou E, Papadopoulos AN, Spantideas N, Bougea A (2022) Migraine, Tension-Type Headache and Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. Med (Kaunas) 58:1684. https:\/\/doi.org\/10.3390\/medicina58111684","journal-title":"Med (Kaunas)"},{"key":"2416_CR104","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/mds.20629","volume":"20","author":"C Brefel-Courbon","year":"2005","unstructured":"Brefel-Courbon C, Payoux P, Thalamas C et al (2005) Effect of levodopa on pain threshold in Parkinson\u2019s disease: a clinical and positron emission tomography study. Mov Disord 20:1557\u20131563. https:\/\/doi.org\/10.1002\/mds.20629","journal-title":"Mov Disord"},{"key":"2416_CR105","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2008.12.004","volume":"141","author":"AG Beiske","year":"2009","unstructured":"Beiske AG, Loge JH, R\u00f8nningen A, Svensson E (2009) Pain in Parkinson\u2019s disease: Prevalence and characteristics. Pain 141:173\u2013177. https:\/\/doi.org\/10.1016\/j.pain.2008.12.004","journal-title":"Pain"},{"key":"2416_CR106","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/neurolint12030014","volume":"12","author":"A Edinoff","year":"2020","unstructured":"Edinoff A, Sathivadivel N, McBride T et al (2020) Chronic Pain Treatment Strategies in Parkinson\u2019s Disease. Neurol Int 12:61\u201376. https:\/\/doi.org\/10.3390\/neurolint12030014","journal-title":"Neurol Int"},{"key":"2416_CR107","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s007020050192","volume":"106","author":"D Berg","year":"1999","unstructured":"Berg D, Becker G, Reiners K (1999) Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica. J Neural Transm (Vienna) 106:725\u2013728. https:\/\/doi.org\/10.1007\/s007020050192","journal-title":"J Neural Transm (Vienna)"},{"key":"2416_CR108","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1474-4422(18)30071-1","volume":"17","author":"N Attal","year":"2018","unstructured":"Attal N, Bouhassira D, Baron R (2018) Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol 17:456\u2013466. https:\/\/doi.org\/10.1016\/S1474-4422(18)30071-1","journal-title":"Lancet Neurol"},{"key":"2416_CR109","doi-asserted-by":"publisher","first-page":"107209","DOI":"10.1016\/j.toxicon.2023.107209","volume":"232","author":"T Grippe","year":"2023","unstructured":"Grippe T, Chen R (2023) Botulinum toxin in the management of parkinsonian disorders. Toxicon 232:107209. https:\/\/doi.org\/10.1016\/j.toxicon.2023.107209","journal-title":"Toxicon"},{"key":"2416_CR110","doi-asserted-by":"publisher","first-page":"100260","DOI":"10.1016\/j.prdoa.2024.100260","volume":"11","author":"A Schonwald","year":"2024","unstructured":"Schonwald A, Amodeo K, Levy V, Danisi F (2024) Botulinum toxin therapy in Parkinson disease-related lower limb dystonia. An 8 year retrospective review. Clin Parkinsonism Relat Disorders 11:100260. https:\/\/doi.org\/10.1016\/j.prdoa.2024.100260","journal-title":"Clin Parkinsonism Relat Disorders"},{"key":"2416_CR111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/WNF.0000000000000016","volume":"37","author":"I Lotan","year":"2014","unstructured":"Lotan I, Treves TA, Roditi Y, Djaldetti R (2014) Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol 37:41\u201344. https:\/\/doi.org\/10.1097\/WNF.0000000000000016","journal-title":"Clin Neuropharmacol"},{"key":"2416_CR112","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ejp.942","volume":"21","author":"A Shohet","year":"2017","unstructured":"Shohet A, Khlebtovsky A, Roizen N et al (2017) Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson\u2019s disease. Eur J Pain 21:486\u2013493. https:\/\/doi.org\/10.1002\/ejp.942","journal-title":"Eur J Pain"},{"key":"2416_CR113","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/jnnp-2013-306907","volume":"85","author":"I Aviles-Olmos","year":"2014","unstructured":"Aviles-Olmos I, Kefalopoulou Z, Tripoliti E et al (2014) Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson\u2019s disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry 85:1419\u20131425. https:\/\/doi.org\/10.1136\/jnnp-2013-306907","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2416_CR114","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00701-009-0281-x","volume":"151","author":"PF Katsakiori","year":"2009","unstructured":"Katsakiori PF, Kefalopoulou Z, Markaki E et al (2009) Deep brain stimulation for secondary dystonia: results in 8 patients. Acta Neurochir (Wien) 151:473\u2013478 discussion 478. https:\/\/doi.org\/10.1007\/s00701-009-0281-x","journal-title":"Acta Neurochir (Wien)"},{"key":"2416_CR115","doi-asserted-by":"publisher","first-page":"507416","DOI":"10.4061\/2011\/507416","volume":"2011","author":"N Hwynn","year":"2011","unstructured":"Hwynn N, Ul Haq I, Malaty IA et al (2011) Effect of Deep Brain Stimulation on Parkinson\u2019s Nonmotor Symptoms following Unilateral DBS: A Pilot Study. Parkinsons Dis 2011:507416. https:\/\/doi.org\/10.4061\/2011\/507416","journal-title":"Parkinsons Dis"},{"key":"2416_CR116","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s00415-009-0908-0","volume":"255","author":"H-J Kim","year":"2008","unstructured":"Kim H-J, Paek SH, Kim J-Y et al (2008) Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol 255:1889\u20131894. https:\/\/doi.org\/10.1007\/s00415-009-0908-0","journal-title":"J Neurol"},{"key":"2416_CR117","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.pain.2012.07.026","volume":"153","author":"E Dellapina","year":"2012","unstructured":"Dellapina E, Ory-Magne F, Regragui W et al (2012) Effect of subthalamic deep brain stimulation on pain in Parkinson\u2019s disease. Pain 153:2267\u20132273. https:\/\/doi.org\/10.1016\/j.pain.2012.07.026","journal-title":"Pain"},{"key":"2416_CR118","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1227\/NEU.0b013e3182266664","volume":"70","author":"H-J Kim","year":"2012","unstructured":"Kim H-J, Jeon BS, Lee J-Y et al (2012) The benefit of subthalamic deep brain stimulation for pain in Parkinson disease: a 2-year follow-up study. Neurosurgery 70:18\u201323 discussion 23\u201324. https:\/\/doi.org\/10.1227\/NEU.0b013e3182266664","journal-title":"Neurosurgery"},{"key":"2416_CR119","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/jamaneurol.2015.8","volume":"72","author":"YJ Jung","year":"2015","unstructured":"Jung YJ, Kim H-J, Jeon BS et al (2015) An 8-Year Follow-up on the Effect of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease. JAMA Neurol 72:504\u2013510. https:\/\/doi.org\/10.1001\/jamaneurol.2015.8","journal-title":"JAMA Neurol"},{"key":"2416_CR120","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11910-016-0628-7","volume":"16","author":"C Geroin","year":"2016","unstructured":"Geroin C, Gandolfi M, Bruno V et al (2016) Integrated Approach for Pain Management in Parkinson Disease. Curr Neurol Neurosci Rep 16:28. https:\/\/doi.org\/10.1007\/s11910-016-0628-7","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2416_CR121","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s10194-025-02198-7","volume":"26","author":"J Cui","year":"2025","unstructured":"Cui J, Qian J, Shi Y et al (2025) Activation of the zona incerta GABAergic circuit for the treatment of pain hypersensitivity in Parkinson\u2019s disease mice model. J Headache Pain 26:244. https:\/\/doi.org\/10.1186\/s10194-025-02198-7","journal-title":"J Headache Pain"},{"key":"2416_CR122","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00415-019-09486-8","volume":"267","author":"K Ossowska","year":"2020","unstructured":"Ossowska K (2020) Zona incerta as a therapeutic target in Parkinson\u2019s disease. J Neurol 267:591\u2013606. https:\/\/doi.org\/10.1007\/s00415-019-09486-8","journal-title":"J Neurol"},{"key":"2416_CR123","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42234-020-00055-3","volume":"6","author":"KV Chakravarthy","year":"2020","unstructured":"Chakravarthy KV, Chaturvedi R, Agari T et al (2020) Single arm prospective multicenter case series on the use of burst stimulation to improve pain and motor symptoms in Parkinson\u2019s disease. Bioelectron Med 6:18. https:\/\/doi.org\/10.1186\/s42234-020-00055-3","journal-title":"Bioelectron Med"},{"key":"2416_CR124","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3233\/JPD-150542","volume":"5","author":"SJ Egan","year":"2015","unstructured":"Egan SJ, Laidlaw K, Starkstein S (2015) Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson\u2019s Disease. J Parkinsons Dis 5:443\u2013451. https:\/\/doi.org\/10.3233\/JPD-150542","journal-title":"J Parkinsons Dis"},{"key":"2416_CR125","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1176\/appi.ajp.2011.10111669","volume":"168","author":"RD Dobkin","year":"2011","unstructured":"Dobkin RD, Menza M, Allen LA et al (2011) Cognitive-behavioral therapy for depression in Parkinson\u2019s disease: a randomized, controlled trial. Am J Psychiatry 168:1066\u20131074. https:\/\/doi.org\/10.1176\/appi.ajp.2011.10111669","journal-title":"Am J Psychiatry"},{"key":"2416_CR126","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1037\/a0035747","volume":"69","author":"DM Ehde","year":"2014","unstructured":"Ehde DM, Dillworth TM, Turner JA (2014) Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol 69:153\u2013166. https:\/\/doi.org\/10.1037\/a0035747","journal-title":"Am Psychol"},{"key":"2416_CR127","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JPD-140508","volume":"5","author":"NE Allen","year":"2015","unstructured":"Allen NE, Moloney N, van Vliet V, Canning CG (2015) The Rationale for Exercise in the Management of Pain in Parkinson\u2019s Disease. J Parkinsons Dis 5:229\u2013239. https:\/\/doi.org\/10.3233\/JPD-140508","journal-title":"J Parkinsons Dis"},{"key":"2416_CR128","doi-asserted-by":"publisher","first-page":"pzab302","DOI":"10.1093\/ptj\/pzab302","volume":"102","author":"JA Osborne","year":"2022","unstructured":"Osborne JA, Botkin R, Colon-Semenza C et al (2022) Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association. Phys Ther 102:pzab302. https:\/\/doi.org\/10.1093\/ptj\/pzab302","journal-title":"Phys Ther"},{"key":"2416_CR129","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41531-025-01042-8","volume":"11","author":"NS Luthra","year":"2025","unstructured":"Luthra NS, Mehta N, Munoz MJ et al (2025) Aerobic exercise-induced changes in fluid biomarkers in Parkinson\u2019s disease. NPJ Parkinsons Dis 11:190. https:\/\/doi.org\/10.1038\/s41531-025-01042-8","journal-title":"NPJ Parkinsons Dis"},{"key":"2416_CR130","doi-asserted-by":"publisher","first-page":"CD002817","DOI":"10.1002\/14651858.CD002817.pub4","volume":"2013","author":"CL Tomlinson","year":"2013","unstructured":"Tomlinson CL, Patel S, Meek C et al (2013) Physiotherapy versus placebo or no intervention in Parkinson\u2019s disease. Cochrane Database Syst Rev 2013:CD002817. https:\/\/doi.org\/10.1002\/14651858.CD002817.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"2416_CR131","doi-asserted-by":"publisher","first-page":"102340","DOI":"10.1016\/j.ctim.2020.102340","volume":"49","author":"E Angelopoulou","year":"2020","unstructured":"Angelopoulou E, Anagnostouli M, Chrousos GP, Bougea A (2020) Massage therapy as a complementary treatment for Parkinson\u2019s disease: A Systematic Literature Review. Complement Ther Med 49:102340. https:\/\/doi.org\/10.1016\/j.ctim.2020.102340","journal-title":"Complement Ther Med"},{"key":"2416_CR132","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/mds.10134","volume":"17","author":"LM Shulman","year":"2002","unstructured":"Shulman LM, Wen X, Weiner WJ et al (2002) Acupuncture therapy for the symptoms of Parkinson\u2019s disease. Mov Disord 17:799\u2013802. https:\/\/doi.org\/10.1002\/mds.10134","journal-title":"Mov Disord"},{"key":"2416_CR133","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ane.13435","volume":"144","author":"AR Qureshi","year":"2021","unstructured":"Qureshi AR, Jamal MK, Rahman E et al (2021) Non-pharmacological therapies for pain management in Parkinson\u2019s disease: A systematic review. Acta Neurol Scand 144:115\u2013131. https:\/\/doi.org\/10.1111\/ane.13435","journal-title":"Acta Neurol Scand"},{"key":"2416_CR134","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/jnnp-2022-330967","volume":"95","author":"G Li","year":"2024","unstructured":"Li G, Huang P, Cui S et al (2024) Effect of long-term Tai Chi training on Parkinson\u2019s disease: a 3.5-year follow-up cohort study. J Neurol Neurosurg Psychiatry 95:222\u2013228. https:\/\/doi.org\/10.1136\/jnnp-2022-330967","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2416_CR135","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","volume":"15","author":"A Zarkali","year":"2024","unstructured":"Zarkali A, Thomas GEC, Zetterberg H, Weil RS (2024) Neuroimaging and fluid biomarkers in Parkinson\u2019s disease in an era of targeted interventions. Nat Commun 15:5661. https:\/\/doi.org\/10.1038\/s41467-024-49949-9","journal-title":"Nat Commun"},{"key":"2416_CR136","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.bionps.2023.100074","volume":"9","author":"KY Yamashita","year":"2023","unstructured":"Yamashita KY, Bhoopatiraju S, Silverglate BD, Grossberg GT (2023) Biomarkers in Parkinson\u2019s disease: A state of the art review. Biomarkers Neuropsychiatry 9:100074. https:\/\/doi.org\/10.1016\/j.bionps.2023.100074","journal-title":"Biomarkers Neuropsychiatry"},{"key":"2416_CR137","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","volume":"36","author":"T Li","year":"2020","unstructured":"Li T, Le W (2020) Biomarkers for Parkinson\u2019s Disease: How Good Are They? Neurosci Bull 36:183\u2013194. https:\/\/doi.org\/10.1007\/s12264-019-00433-1","journal-title":"Neurosci Bull"},{"issue":"Suppl 1","key":"2416_CR138","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","volume":"22","author":"M Delenclos","year":"2016","unstructured":"Delenclos M, Jones DR, McLean PJ, Uitti RJ (2016) Biomarkers in Parkinson\u2019s disease: Advances and strategies. Parkinsonism Relat Disord 22(Suppl 1):S106\u2013110. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.09.048","journal-title":"Parkinsonism Relat Disord"},{"key":"2416_CR139","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","volume":"15","author":"J H\u00e4llqvist","year":"2024","unstructured":"H\u00e4llqvist J, Bartl M, Dakna M et al (2024) Plasma proteomics identify biomarkers predicting Parkinson\u2019s disease up to 7 years before symptom onset. Nat Commun 15:4759. https:\/\/doi.org\/10.1038\/s41467-024-48961-3","journal-title":"Nat Commun"},{"key":"2416_CR140","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40122-025-00718-6","volume":"14","author":"T Asimakopoulos","year":"2025","unstructured":"Asimakopoulos T, Tsaroucha A, Kouri M et al (2025) The Role of Biomarkers in Acute Pain: A Narrative Review. Pain Ther 14:775\u2013789. https:\/\/doi.org\/10.1007\/s40122-025-00718-6","journal-title":"Pain Ther"},{"key":"2416_CR141","doi-asserted-by":"publisher","unstructured":"Diaz MM, Caylor J, Strigo I et al (2022) Toward composite pain biomarkers of neuropathic pain\u2014focus on peripheral neuropathic pain. Front Pain Res 3. https:\/\/doi.org\/10.3389\/fpain.2022.869215","DOI":"10.3389\/fpain.2022.869215"},{"key":"2416_CR142","doi-asserted-by":"publisher","DOI":"10.4081\/ahr.2024.4","author":"T Asimakopoulos","year":"2024","unstructured":"Asimakopoulos T, Kourousi M, Varrassi G, Rekatsina M (2024) Piezo channels in migraine and trigeminal pain syndromes: a systematic review of their role in pain pathways. Adv Health Res. https:\/\/doi.org\/10.4081\/ahr.2024.4. 1:","journal-title":"Adv Health Res"},{"key":"2416_CR143","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R et al (2023) Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease. Cells 12:1012. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"key":"2416_CR144","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"Tansey MG, Romero-Ramos M (2019) Immune system responses in Parkinson\u2019s disease: Early and dynamic. Eur J Neurosci 49:364\u2013383. https:\/\/doi.org\/10.1111\/ejn.14290","journal-title":"Eur J Neurosci"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02416-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02416-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02416-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:45:36Z","timestamp":1786437936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02416-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02416-w","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"204"}}